Neuropace Inc (NQ: NPCE )
6.460
-0.220
(-3.29%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 14, 2024
Add to My Watchlist
Headline News about Neuropace Inc
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
The Latest Analyst Ratings For NeuroPace
March 12, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Recap: NeuroPace Q4 Earnings
March 05, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/10/growthstocks_1600_02.jpg)
![](/next-assets/images/schema-image-default.png)
Earnings Preview: NeuroPace
March 04, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
A Glimpse Into The Expert Outlook On NeuroPace Through 4 Analysts
February 22, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
NeuroPace Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
January 30, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Breaking Down NeuroPace: 6 Analysts Share Their Views
December 27, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Expert Ratings for NeuroPace
December 04, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Expert Ratings for NeuroPace
November 10, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
NeuroPace's Return On Capital Employed Overview
May 18, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/11/10/aapharma_5.png?width=1200&height=800&fit=crop)
Epilepsy-Focused MedTech NeuroPace Has Attractive Entry Point, Competitive Position
November 10, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's After-Market Session
November 06, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/09/06/image10.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 29, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 29, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Recap: NeuroPace Q1 Earnings
May 04, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Looking Into NeuroPace's Return On Capital Employed
March 08, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/08/29/image24_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Friday's Intraday Session
August 25, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2023
August 24, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 08, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/Los,Angeles,-,Feb,22:,Elon,Musk,At,The,Vanity.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/03/image48.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Friday's Intraday Session
March 03, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.